A Phase 1 Dose Escalation Study of Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor PRT543 in Patients with Myeloid Malignancies

被引:13
|
作者
Patel, Manish R. [1 ]
Monga, Varun [2 ]
Jauhari, Shekeab [1 ]
Stevens, Don [3 ]
Masarova, Lucia [4 ]
McKean, Meredith [5 ]
Mauro, David [6 ]
Viscusi, John [6 ]
Scherle, Peggy [6 ]
Bhagwat, Neha [6 ]
Moore, Andrew [6 ]
Sun, William [6 ]
Chiaverelli, Rachel [6 ]
Mintah, Eric [6 ]
Nath, Rajneesh [7 ]
Stein, Eytan M. [8 ]
Palmisiano, Neil [9 ]
Sutamtewagul, Grerk [2 ]
Verstovsek, Srdan [10 ]
机构
[1] Florida Canc Specialists & Res Inst, Sarah Cannon Res Inst, Sarasota, FL USA
[2] Univ Iowa Hosp & Clin, Dept Med, Iowa City, IA 52242 USA
[3] NCI, Norton Healthcare, Louisville, KY USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[5] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[6] Prelude Therapeut, Res & Dev, Wilmington, DE USA
[7] Univ Texas MD Anderson Canc Ctr, Banner Hlth, Gilbert, AZ USA
[8] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA
[9] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA
[10] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2021-150938
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2609
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Identification of protein arginine N-methyltransferase 5 (PRMT5) as a novel interacting protein with the tumor suppressor protein RASSF1A
    Sakai, Nobuya
    Saito, Yumiko
    Fujiwara, Yoko
    Shiraki, Takashi
    Imanishi, Yorihisa
    Koshimizu, Taka-aki
    Shibata, Katsushi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 467 (04) : 778 - 784
  • [42] Research Progress on Small-molecule Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5) for Treating Cancer
    Guo, Chaohua
    Wu, Lintao
    Zheng, Xumei
    Zhao, Lin
    Hou, Xiaojia
    Wang, Zhijun
    Han, Chun
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (21) : 2048 - 2074
  • [43] Protein Arginine Methyltransferase 5 (Prmt5) Is Required for Germ Cell Survival During Mouse Embryonic Development
    Wang, Yanbo
    Li, Qiuling
    Liu, Chunyi
    Han, Feng
    Chen, Min
    Zhang, Lianjun
    Cui, Xiuhong
    Qin, Yan
    Bao, Shilai
    Gao, Fei
    BIOLOGY OF REPRODUCTION, 2015, 92 (04)
  • [44] Type II protein arginine methyltransferase 5 (PRMT5) is required for circadian period determination in Arabidopsis thaliana
    Hong, Sunghyun
    Song, Hae-Ryong
    Lutz, Kerry
    Kerstetter, Randall A.
    Michael, Todd P.
    McClung, C. Robertson
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (49) : 21211 - 21216
  • [45] EFFECT OF THE PROTEIN ARGININE METHYLTRANSFERASE PRMT5 INHIBITION IN GLIOMA STEM-LIKE CELLS
    Mittal, Sandeep
    Shaw, Vikram
    Piao, Yuji
    Park, Soon Young
    Sriram, Sai
    Dong, Jianwen
    Martinez-Ledesma, Emmanuel
    Henry, Verlene
    Ezhilarasan, Ravesanker
    Sulman, Erik
    Balasubramaniyan, Veerakumar
    de Groot, John
    NEURO-ONCOLOGY, 2018, 20 : 87 - 87
  • [46] Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations
    Zhu, Kongkai
    Jiang, Chengshi
    Tao, Hongrui
    Liu, Jingqiu
    Zhang, Hua
    Luo, Cheng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (09) : 1476 - 1483
  • [47] Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5
    Zhang, Baolai
    Zhang, Su
    Zhu, Lijuan
    Chen, Xue
    Zhao, Yunfeng
    Chao, Li
    Zhou, Juanping
    Wang, Xing
    Zhang, Xinyang
    Ma, Nengqian
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 336 : 1 - 7
  • [48] Alternative Splicing Analysis Reveals Adrenergic Signaling as a Novel Target for Protein Arginine Methyltransferase 5 (PRMT5) in the Heart
    Jiao, Shouye
    Zhang, Yimeng
    Yang, Xiao
    Wang, Jian
    Li, Zhenhua
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [49] Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization
    Mao, Ruifeng
    Shao, Jingwei
    Zhu, Kongkai
    Zhang, Yuanyuan
    Ding, Hong
    Zhang, Chenhua
    Shi, Zhe
    Jiang, Hualiang
    Sun, Dequn
    Duan, Wenhu
    Luo, Cheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (14) : 6289 - 6304
  • [50] The protein arginine methyltransferase PRMT5 promotes D2-like dopamine receptor signaling
    Likhite, Neah
    Jackson, Christopher A.
    Liang, Mao-Shih
    Krzyzanowski, Michelle C.
    Lei, Pedro
    Wood, Jordan F.
    Birkaya, Barbara
    Michaels, Kerry L.
    Andreadis, Stelios T.
    Clark, Stewart D.
    Yu, Michael C.
    Ferkey, Denise M.
    SCIENCE SIGNALING, 2015, 8 (402)